)
)
BioMarin Pharmaceutical Investor Relations Material
Latest events
Investor Day 2024
BioMarin Pharmaceutical
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from BioMarin Pharmaceutical Inc
Access all reports
BioMarin Pharmaceueutical Inc. is a biopharmaceutical company that develops and commercializes innovative therapies for people with serious and life-threatening rare diseases and medical conditions.
Key slides for BioMarin Pharmaceutical Inc
Q1 2024
BioMarin Pharmaceutical Inc
Q2 2024
BioMarin Pharmaceutical Inc
Latest articles
)
Cristiano Amon: Qualcomm's 5G Specialist CEO
Cristiano Amon, Qualcomm CEO, has spent two decades at the company while taking on several roles, developing both technical and business expertise.
16 Sep 2024
)
Qualcomm: Quality Communication and Semiconductor Innovation
Founded in 1985, Qualcomm has transformed the digital communication industry with CDMA technology and its advanced semiconductor business.
13 Sep 2024
)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Ticker symbol
BMRN
Country
🇺🇸 United States